A February disclosure shows the household of Michael T. McCaul, the Texas Republican who chairs the House Foreign Affairs Committee, purchased as much as $100,000 worth of medical products maker BAX — Baxter International Inc.
The trade, reported under the STOCK Act’s periodic transaction disclosure rules, lists the buyer as McCaul’s spouse and places the value in the $50,000–$100,000 range. Using the midpoint of that band, the purchase represents roughly a $75,000 investment in the hospital equipment supplier.
Baxter is a longstanding manufacturer of hospital supplies and medical devices, with a product lineup that includes IV solutions, infusion systems, surgical products, and renal care technologies used in dialysis. Because many of those products are embedded in everyday hospital workflows, the company has historically benefited from recurring demand tied to hospital utilization and procedure volumes.
Details of the trade
- Date: Feb. 17, 2026
- Action: Buy
- Amount: $50,000–$100,000
- Owner: Spouse
Baxter shares recently traded around $17.40, giving the company a market capitalization of roughly $9.0 billion on the New York Stock Exchange. Investors often follow the company for signals about hospital spending trends and procedure volumes, as well as its ongoing portfolio restructuring within the broader medical technology sector.
Congressional trading data shows that Baxter has drawn interest from lawmakers across parties over time. At least 27 members of Congress have reported trades in the stock, reflecting the company’s long-standing presence in the healthcare equipment market.
McCaul himself is among the more active investors in Congress. Disclosure data shows more than 17,500 career trades reported under his name, a figure that places him near the top of lawmakers by transaction volume over time.
While Baxter operates squarely within the healthcare sector, McCaul’s committee assignments are focused primarily on national security and diplomacy. He serves on the House Committee on Homeland Security and the House Committee on Foreign Affairs, including subcommittee work covering Europe and the East Asia and Pacific regions.
Under the 2012 STOCK Act, lawmakers and their families are permitted to trade individual stocks but must publicly disclose transactions within a set timeframe. Those disclosures allow the public to track activity such as this Baxter purchase alongside other latest congressional trades.
Baxter’s broad installed base across hospitals and dialysis clinics has long made it a closely watched name in medical technology investing. Its mix of equipment and consumables means revenue is often tied to both device placements and the ongoing use of related disposables.
The February purchase by the McCaul household adds to the list of congressional investors with exposure to the company as it navigates shifts in hospital demand and strategic changes within its product portfolio.